Yüklüyor......
"Flagellated" cancer cells propel anti-tumor immunity
The use of innate immune receptor agonists in cancer therapies has suffered from many drawbacks. Our recent observations suggest that some of these hurdles can be overcome by introducing flagellin into tumor cells to promote tumor antigen presentation by dendritic cells (DCs) and simultaneously trig...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Landes Bioscience
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3489752/ https://ncbi.nlm.nih.gov/pubmed/23162764 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.20305 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|